Endurance Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5
Closed -$2K 652
2020
Q4
$2K Sell
5
-25
-83% -$7.67K ﹤0.01% 571
2020
Q3
$8K Hold
30
﹤0.01% 495
2020
Q2
$8K Hold
30
﹤0.01% 479
2020
Q1
$7K Buy
30
+5
+20% +$1.36K ﹤0.01% 452
2019
Q4
$8K Hold
25
﹤0.01% 436
2019
Q3
$6K Hold
25
﹤0.01% 445
2019
Q2
$7K Hold
25
﹤0.01% 402
2019
Q1
$7K Hold
25
﹤0.01% 399
2018
Q4
$7K Buy
+25
New +$6.87K ﹤0.01% 390

Other funds holding ELV

Endurance Wealth Management's ELV Position: Q1 2021 in Review

Endurance Wealth Management sold out of Elevance Health (ELV) in Q1 2021, closing a stake of 5 shares — an estimated $2K sold.

Endurance Wealth Management first reported a position in ELV in Q4 2018 and held it in 9 quarters. The position peaked at $8K in Q3 2020. 1,211 funds tracked by Wall St. Rank hold ELV as of Q1 2021.

  • Endurance Wealth Management reported no remaining Elevance Health position as of Q1 2021 after selling out during the quarter.
  • Endurance Wealth Management sold 5 Elevance Health shares in Q1 2021, an estimated $2K.
  • Endurance Wealth Management first reported a position in Elevance Health in Q4 2018 and held it in 9 quarters.
  • Endurance Wealth Management's Elevance Health position peaked at $8K in Q3 2020.
  • 1,211 funds tracked by Wall St. Rank held Elevance Health as of Q1 2021.

Based on Endurance Wealth Management's 13F filing for Q1 2021, filed 5 May 2021.